CDMO Profile

Rentschler Biopharma

Rentschler Biopharma Contract Manufacturing & Development (CDMO) Profile

At Rentschler Biopharma, reliability you can trust is more than a promise—it’s our commitment.
As a global leader in Contract Development and Manufacturing Organization (CDMO) services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023.

CDMO Services:
Biologics; Cell & Gene Therapy

Year Founded: 1872

Head Office: Laupheim, Germany

Number of Facilities: 3-5

Facility locations: Europe; North America

Website: Visit the Rentschler Biopharma website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.